한국형 양극성 장애 약물치료 알고리듬 2022: 소아/청소년

• 영문명: Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents
• 발행기관: 대한신경정신의학회
• 저자명: 양찬모 박원명 우영섭 정종현 서정석 추일한 김원 이정구 정명훈 전덕인 박성용 손인기 김문두 윤보현 심세훈
• 간행물 정보: 『신경정신의학』제61권 제3호, 224~236쪽, 전체 13쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2022.08.31

영문 초록

Objectives The objective of this study was to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2022: children and adolescents. Methods We performed a survey, using a questionnaire comprising 23 questions according to various situations facing children and adolescents with bipolar disorders. A total of 40 of the 60 experts in child and adolescent psychiatry responded to the survey. Results The first-line pharmacotherapeutic strategies for manic and depressive episodes in children with bipolar disorders were a combination of mood stabilizer (MS) and atypical antipsychotics (AAP). The first-line medications selected for these children were aripiprazole (treatme f choice, TOC) and risperidone. The first-line pharmacotherapeutic strategies for manic episodes in adolescents were a combination of MS and an AAP (TOC), monotherapy with MS, andmonotherapy with an AAP. Lithium, valproate, aripiprazole, risperidone, and quetiapine were selected as first-line medications for these adolescents. First-line pharmacotherapeutic strategiesfor depressive episodes in adolescents were a combination of MS and an AAP, monotherapywith MS, and monotherapy with an AAP. The first-line pharmacotherapeutic strategies for thedepressive episodes in adolescents at high risk for bipolar disorder were a combination of MSand AAP and monotherapy with an AAP. Lithium, valproate, aripiprazole (TOC), quetiapine, andrisperidone were selected as first-line medications for the treatment of depressive episodes inadolescents with bipolar disorder. Conclusion It is expected that the present KMAP-BP 2022: children and adolescents will givethe direction and be usefully applied by clinicians to treat children and adolescents with bipolardisorders.

목차

서 론

방 법

결 과

고 찰

결 론

REFERENCES

키워드

양극성 장애 소아/청소년 약물치료 Bipolar disorder Children and adolescents Pharmacotherapy KMAP-BP 2022